Objective: The non-classical major histocompatibility complex (MHC) class I chain related molecules (MIC), encoded within the MHC, function in immunity. The transmembrane polymorphism in MICA (MICA-STR) has been reported to be associated with type 1 diabetes. In this study we directly sequenced both of the highly polymorphic MIC genes (MICA and MICB) in order to establish if they are associated with type 1 diabetes independently of the known type 1 diabetes MHC class II genes, HLA-DRB1 and HLA-DQB1.
Introduction Approximately 50% of the familial clustering of type 1 diabetes is attributable to the major histocompatibility complex (MHC) region on human chromosome 6p21 and the MHC class II genes, HLA-DRB1 and HLA-DQB1, account for a large proportion of this clustering (1) . However, association studies in the MHC region indicate other genes have effects in type 1 diabetes independently of the class II genes (2) (3) (4) . Identification of these genes is complicated because genes in the MHC have multiple alleles, exhibit extensive linkage disequilibrium (LD) and the class II genes, HLA-DQB1 and HLA-DRB1, show complicated dominance and epistatic effects. Importantly, any putative new effect must be distinguished from the effect of these class II genes (2; 3).
he non-classical MHC class I chain related molecule (MIC) genes MICA and MICB are located 46.4 kb and 141.2 kb centromeric of HLA-B and ~2 Mb telomeric of HLA-DRB1 (5) and have been associated both with immunity and with autoimmune diseases (5) . In common with most MHC HLA genes, "alleles" of MICA and MICB are named based on haplotypes of nonsynonymous single nucleotide polymorphisms (nsSNPs). However, the most studied polymorphism in either of these genes is a short tandem repeat (STR) in the transmembrane domain of MICA (MICA-STR). Whether or not these genes are associated with type 1 diabetes is uncertain with multiple conflicting reports in the literature (3; 6-14) . Most of these studies failed to demonstrate convincingly that the association is independent of the MHC class II genes and all were restricted to analyses of the MICA-STR. The MICA-STR is a GCT repeat microsatellite in MICA exon 5 (alleles of the MICA-STR are named based on the number of repeat units). In European populations the most common allele of the MICA-STR is MICA-STR*A5.1 (frequency 0.50), which contains five GCT repeats and a G insertion that causes a frame shift leading to a premature stop codon and the truncation of the cytoplasmic tail (MICA-STR*A5 contains five GCT repeats but not the G insertion and is in frame). Here, we genotyped the MICA-STR in a large case control collection. However, different alleles of the MICA-STR associate with multiple alleles of other polymorphisms in MICA (5) . Therefore, to capture the allelic variation of MICA more comprehensively, we designed a sequencing based typing (SBT) method that yields the genotype information for both MICA and MICB for exons 2-5 and used it to genotype two collections of type 1 diabetes families. Various approaches have been described to obtain a complete genotype of the MICA and MICB genes (15; 16). Our method is similar to other SBT methods but incorporates a novel scoring method that increases throughput.
MATERIALS AND METHODS
MICA and MICB share 83% DNA sequence homology. Each gene consists of six exons: exon 1, which codes for a signal peptide, exons 2-4 for three extracellular domains (α1, α2 and α3), exon 5 for a transmembrane domain and exon 6 for a carboxy-terminal cytoplasmic tail (5) . Genotyping of the MICA-STR. Genotyping of the MICA-STR was done using PCR (Online-Only Appendix Note 1) followed by capillary electrophoresis of the amplified product (17) . We used primers CCTTTTTTTCAGGGAAAGTGC (FAMlabelled) and CCTTACCATCTCCAGAAACTG. Sequencing-based typing of the MICA and MICB genes. Our aim was to maximise throughput in order to enable analysis of large sample sets, and therefore, we used a system that gave the most genotype information while minimising the amount of sequencing and the cost. For this reason we limited ourselves to the information that could be captured with a single pair of external primers. In both genes exon 1 is ~8.5 kb from exon 2, exons 2-5 are in close proximity to each other in a ~2 kb segment and exon 6 is ~2.25 kb centromeric of exon 5. Our MICA primers amplified a 1.9 kb fragment containing exons 2, 3 and 4; the MICA-STR is at the beginning of the exon 5 of MICA, and therefore, it was not possible to sequence through exon 5 We aligned and scored sequence reads using the Gap4 program from the Staden package (http://www.mrclmb.cam.ac.uk/pubseq/).
To increase throughput we included a consensus trace in the alignment. Sequence data is not phased and, therefore, a method was needed to determine which pair of alleles was present. While there are many nsSNPs in the MIC genes, they give rise to relatively few alleles per gene. The common alleles are listed on the IMGT/HLA Sequence Database (http://www.anthonynolan.org.uk/HIG/data. html) (18) . Since the possible genotypes were limited and known, we used in-house software similar to the Helmberg Score software (19) . Positions that varied were extracted from the static alignments of the IMGT/HLA Sequence Database. The alleles were reduced to just those SNPs that are present in the regions we sequenced. A file was then constructed of all possible pairs of MICA or MICB alleles. Our sequence data was extracted in the same format, and the two files compared. Ambiguity created by missing SNP values was clarified by examining familial relationship and the MICA-STR data.
We (20) and the USA Human Biological Data Interchange (HBDI) collection (340 four and five member families including more than one affected sibling and both parents) (21) . In addition we genotyped the MICA-STR in 2,023 UK type 1 diabetes cases and 1,748 geographically matched controls (22) . All collections comprised subjects of white European origin. HLA-DRB1 and HLA-DQB1 had been genotyped previously in these subjects using Dynal RELI SSO assays (Invitrogen Ltd, Paisley, UK) (2). Statistical analysis. Statistical analyses were carried out in the statistical package STATA v9 (http://www.stata.com) and the rpart library in R was used for the recursive partitioning (23; 24) .
Each MIC locus was first tested for association with type 1 diabetes without conditioning on the MHC class II loci. Sets of cases and matched pseudo-controls were generated from the affected sib-pair (ASP) families, and analysed using conditional logistic regression (25) with Huber-White sandwich estimators, to correct for the nonindependence of siblings. In the case-control collection, cases and controls were matched to 12 broad geographical regions across Great Britain(Northern, East and West Ridings, North Midland, Eastern, Southeastern, Southern, Southwestern, Wales, Midlands, Scotland, London, Northwestern) (22) and analysed using logistic regression (22) . The alleles of the MIC loci were modelled assuming a multiplicative mode of inheritance.
To establish whether any observed associations of MICA and MICB were independent of, and not due to LD with, the class II genes, HLA-DRB1 and HLA-DQB1, the effects of these highly associated loci must be taken into account in the analysis of MICA and MICB. The overall number of class II alleles, which includes many rare alleles, and the well-established nonmultiplicative effects of these loci, complicates their modelling. We found recursive partitioning (rpart) was an effective method to model the genotypes of HLA-DRB1 and HLA-DQB1 (2) . This is a risk-based grouping method that categorises individuals as affected or unaffected based on their MHC class II genotypes (2) . The resulting groups of MHC class II genotypes define strata within which additional, nonclass II, associations can be tested, using either conditional logistic regression (families) or logistic regression (case/control) (2). The rpart method was performed both in the case/controls and in the families (cases/pseudo-controls). The additional MHC class II independent effect of each MIC locus, was tested by adding the alleles of the test locus to the logistic model and testing their independent effects by a Wald test (families) or a likelihood ratio test (case/control). Note that all the alleles of MICA or of MICB were included in the logistic model, which allows testing of the conditional association of the locus and calculation of the conditional relative risks (RR)/odds ratios (ORs) of the individual alleles simultaneously, relative to a common reference allele.
For the most common allele of the MICA-STR (MICA-STR*A5.1), which has a minor allele frequency of 0.5, our power to detect an effect size of OR 2 is greater than 98% at α = 10 -5 . -9 ). However, if the effect of these genes is conditioned on HLA-DRB1 and HLA-DQB1 the association with type 1 diabetes disappears (MICB P=0.03, MICA P=0.08, MICA-STR P=0.76). Note that P=0.03 cannot be considered as evidence of association as it is produced as a result of using a Wald test that is artificially biased towards the alternative hypothesis with rare data (rare alleles, below 0.01, were analysed together, the resulting group had frequency 0.014). Use of a likelihood ratio test without robust variance estimates produces a less significant P-value, P=0.1.
RESULTS

Alleles and haplotypes. In
In Table 2 we present the RR for the alleles of MICA and MICB in the UK and USA families, using the most common alleles (MICA*008 and MICB*005) as reference, as they give the tightest 95% confidence intervals. Since none of the other alleles were significantly different to the reference, the reference alleles themselves are also not associated. The MICA-STR was also not associated with type 1 diabetes after conditioning on HLA-DRB1 and HLA-DQB1 neither in the case/control collection (P=0.65 for the individual alleles and P=0.91 for the genotypes), nor in the families (P=0.76) ( Table 3) . We also tested the association of MICA-STR*A5.1 genotypes against all the other genotypes grouped together. They were not associated with type 1 diabetes risk after conditioning (Table 4) . We found that all MICA and MICB alleles were in strong LD (D´ > 0.9) with one or more HLA-DRB1 or HLA-DQB1 alleles (Online-Only Appendix Table 2 and  Table 3 ).
DISCUSSION
Our SBT method allows for large-scale and detailed genotyping of the full MICA and MICB alleles. SBT also allows discovery of novel alleles and, indeed, we found four new, rare, variants for MICB. These results illustrate the high level of allelic variability found in the MICA and MICB genes; implying that this variability has yet to be fully characterised.
Previous and ongoing studies of type 1 diabetes associations (including the Type 1 Diabetes Genetics Consortium (www.t1dgc.org) and the IHWG (http://www.ncbi.nlm.nih.gov/projects/mhc/ ihwg.cgi?cmd=DS&ID=11)) have either omitted MICA and MICB or focused on the MICA-STR, because of the costs and complications associated with obtaining the full genotypes of MICA and MICB. Many published reports have identified one or more of the alleles or genotypes of the MICA-STR as being associated with type 1 diabetes. However, some of these studies did not condition adequately on the MHC class II genes (12) (13) (14) , while others used subgroup analysis to analyse the MICA-STR in samples chosen to have particular class II genotypes (7-9; 11) . This sub-grouping causes a multiple testing problem and reduces the sample set, and hence the power to detect MHC class II independent effect. We conclude that, in the European populations analysed here, the common MICA and MICB alleles are unlikely to affect type 1 diabetes susceptibility nor are they markers for the strong, independent, associations of the common alleles of HLA-B (HLA-B39) and HLA-A (2). 
